Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
Holding ELTX?
Track your performance easily
ELTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.96 - $11.45
Previous Close$5.08
Volume12.38K
Average Volume (3M)14.53K
Market Cap
$49.67M
Enterprise Value$52.69M
Total Cash (Recent Filing)$3.40M
Total Debt (Recent Filing)$6.42M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.00
Shares Outstanding10,774,574
10 Day Avg. Volume20,257
30 Day Avg. Volume14,530
Standard Deviation0.26
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-33.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.49
Forecast
1Y Price Target
$9.50Price Target Upside87.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Elicio Therapeutics News
PremiumCompany Announcements
Elicio Therapeutics Appoints Robert Connelly as Financial Officer
PremiumCompany Announcements
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
PremiumPre-Earnings
Is ELTX a Buy, Before Earnings?Ownership Overview
35.43% Insiders
2.84% Mutual Funds
0.13% Other Institutional Investors
59.18% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ELTX FAQ
What was Elicio Therapeutics’s price range in the past 12 months?
Elicio Therapeutics lowest stock price was $2.96 and its highest was $11.45 in the past 12 months.
What is Elicio Therapeutics’s market cap?
Currently, no data Available
When is Elicio Therapeutics’s upcoming earnings report date?
Elicio Therapeutics’s upcoming earnings report date is Mar 28, 2025 which is in 138 days.
How were Elicio Therapeutics’s earnings last quarter?
Currently, no data Available
Is Elicio Therapeutics overvalued?
According to Wall Street analysts Elicio Therapeutics’s price is currently Undervalued.
Does Elicio Therapeutics pay dividends?
Elicio Therapeutics does not currently pay dividends.
What is Elicio Therapeutics’s EPS estimate?
Elicio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elicio Therapeutics have?
Elicio Therapeutics has 10,774,574 shares outstanding.
What happened to Elicio Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Elicio Therapeutics?
Currently, no hedge funds are holding shares in ELTX
---
Elicio Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.50 (87.01% Upside)
$9.50 (87.01% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▲ 11.2%
Last 30 Days ▲ 11.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.93%
12-Months-Change
Fundamentals
Return on Equity
-353.01%
Trailing 12-Months
Asset Growth
-58.13%
Trailing 12-Months
Company Description
Elicio Therapeutics
Angion Biomedica Corp was incorporated in the State of Delaware on April 6. 1998. It is a clinical stage biopharmaceutical company. The Company discovers and develops novel therapeutic agents to treat acute and chronic organ injury by harnessing the body's protective, reparative and regenerative systems. It is developing therapeutics for both orphan indications and large clinical markets of unmet medical need.
---
ELTX Stock 12 Month Forecast
Average Price Target
$9.50
▲(87.01% Upside)
Technical Analysis
Best Analysts Covering ELTX
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-17.80%
reiterated a buy rating 3 months ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -17.80% per trade.
---